Forsight Robotics develops the ORYOM™, a hybrid intraocular robotic ophthalmic platform designed to advance eye surgery. This system leverages high-precision robotics and advanced visualization to provide consistent, reliable surgical procedures for conditions like cataract and glaucoma. The platform aims to improve global access to high-quality ophthalmic care by standardizing surgical skills.
Funding
$65.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The demand for surgical eye care is increasing globally, but there is a shortage of trained ophthalmic surgeons. Traditional ophthalmic surgery relies on highly skilled manual procedures, which can be time-consuming, lead to variable outcomes, and limit access to care.
Solution
ForSight Robotics offers ORYOM™, a hybrid intraocular robotic platform designed to enhance the precision, consistency, and accessibility of ophthalmic surgeries. The platform combines robotic assistance with advanced visualization and cognitive data analytics to improve surgical outcomes. ORYOM™ aims to address the shortage of trained surgeons by providing best-in-class surgical skills and enabling consistent, reliable procedures on a global scale. The system supports a range of ophthalmic procedures, including cataract and glaucoma surgeries, as well as subretinal delivery and treatments for retinal diseases.
Target Audience
The primary target audience includes ophthalmic surgeons, hospitals, and eye clinics seeking to improve surgical precision, consistency, and patient access to care.
Features
- Robotic hand for precise and stable instrument manipulation during surgery
- Advanced visualization system providing enhanced views of the surgical field
- Cognitive data analytics for real-time surgical guidance and performance optimization
- Support for various ophthalmic procedures, including cataract, glaucoma, subretinal delivery, and retinal disease treatments